HomeCompareHCBN vs JNJ

HCBN vs JNJ: Dividend Comparison 2026

HCBN yields 2.07% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HCBN wins by $422.1K in total portfolio value
10 years
HCBN
HCBN
● Live price
2.07%
Share price
$67.54
Annual div
$1.40
5Y div CAGR
64.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$452.4K
Annual income
$273,516.12
Full HCBN calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — HCBN vs JNJ

📍 HCBN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHCBNJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HCBN + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HCBN pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HCBN
Annual income on $10K today (after 15% tax)
$176.19/yr
After 10yr DRIP, annual income (after tax)
$232,488.70/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, HCBN beats the other by $228,502.71/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HCBN + JNJ for your $10,000?

HCBN: 50%JNJ: 50%
100% JNJ50/50100% HCBN
Portfolio after 10yr
$241.3K
Annual income
$139,102.76/yr
Blended yield
57.64%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

HCBN
No analyst data
Altman Z
0.0
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HCBN buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHCBNJNJ
Forward yield2.07%2.13%
Annual dividend / share$1.40$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR64.5%28%
Portfolio after 10y$452.4K$30.3K
Annual income after 10y$273,516.12$4,689.40
Total dividends collected$414.0K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: HCBN vs JNJ ($10,000, DRIP)

YearHCBN PortfolioHCBN Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,041$340.98$10,592$272.30+$449.00HCBN
2$12,393$578.79$11,289$357.73+$1.1KHCBN
3$14,259$998.76$12,123$472.89+$2.1KHCBN
4$17,024$1,766.71$13,141$629.86+$3.9KHCBN
5$21,458$3,242.77$14,408$846.81+$7.0KHCBN
6$29,244$6,283.99$16,021$1,151.60+$13.2KHCBN
7$44,458$13,166.36$18,122$1,588.22+$26.3KHCBN
8$78,342$30,771.90$20,930$2,228.20+$57.4KHCBN
9$167,190$83,364.73$24,792$3,191.91+$142.4KHCBN
10$452,410$273,516.12$30,274$4,689.40+$422.1KHCBN

HCBN vs JNJ: Complete Analysis 2026

HCBNStock

HCB Financial Corp. operates as the bank holding company for Highpoint Community Bank that provides various banking products and services in Michigan. The company offers various personal banking services, including checking and savings accounts; mortgage, home equity, and personal loans; and overdraft services. It also provides business banking services comprising business checking and savings accounts; business loan services, such as real estate lending, lines of credit, and term loans; small business administration loans; other services consisting of sweep and courier banking services, merchant credit card services, night depository services, wire services, health savings accounts, and business mentoring; and overdraft and digital services. In addition, the company offers trust and investment services; electronic banking services, including mobile, telephone, and online banking, mobile deposit, eStatements, and bill pay services; and debit and ATM, credit, gift, and reloadable cards. Further, it provides wealth management services, including investment management, personal trust administration, estate administration, individual retirement account, asset protection and risk management, investment and retirement planning, financial planning, and asset accumulation. Additionally, the company offers insurance services, which include life, health, and disability insurance, and education planning; and annuities, bonds, IRAs, mutual funds, and stocks products. The company operates seven full-service banking offices in Barry County. HCB Financial Corp. was founded in 1886 and is headquartered in Hastings, Michigan.

Full HCBN Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this HCBN vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HCBN vs SCHDHCBN vs JEPIHCBN vs OHCBN vs KOHCBN vs MAINHCBN vs ABBVHCBN vs MRKHCBN vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.